VHM — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Metagenomimetagenomi.co in 𝕏Aug 2019SEC filingmedium confidence

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)

BoardJak Knowles(Director)

Board seatAndrew Farquharson· per SEC Form D · $27.3M raise · filed Aug 2019

Co-investorsCatalio Capital Management, LP RA Capital Sozo Ventures Agent Capital Frazier Life Sciences Humboldt +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.